Loading...
Loading...
Novo Nordisk A/S
NVO reported a 19% rise in its fourth-quarter profit.
Novo Nordisk's quarterly net profit climbed to 4.68 billion kroner ($825 million), from 3.95 billion kroner, in the year-ago period. Its sales surged 12% to 18.12 billion kroner ($3.2 billion) from 16.12 billion.
For the year ahead, Novo Nordisk projects sales growth of 7% to 11%.
Novo Nordisk shares gained 3.93% to $125.48 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in